-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $38

Benzinga·11/05/2025 15:48:14
Listen to the news
Cantor Fitzgerald analyst Kristen Kluska maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price target from $32 to $38.